Skip to main content
Type at least 3 characters

181 articles

Original Research

Published on 30 May 2023

Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice

in Pharmacology of Infectious Diseases

  • Shimaa Abd El-Salam El-Sayed
  • El-Sayed El-Alfy
  • Mohamed Z. Sayed-Ahmed
  • Uday Kumar Mohanta
  • Saad S. Alqahtani
  • Nawazish Alam
  • Sarfaraz Ahmad
  • Md Sajid Ali
  • Ikuo Igarashi
  • Mohamed Abdo Rizk
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1192999
  • 2,792 views
  • 2 citations

Clinical Trial

Published on 23 May 2023

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study

in Pharmacology of Infectious Diseases

  • Shanshan Li
  • Xiaojie Wu
  • Nanyang Li
  • Guoying Cao
  • Jingjing Wang
  • Yuancheng Chen
  • Size Li
  • Jinjie He
  • Jufang Wu
  • Haijing Yang
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1117293
  • 3,235 views
  • 3 citations

Original Research

Published on 19 Apr 2023

Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach

in Pharmacology of Infectious Diseases

  • Shopnil Akash
  • Arafat Hossain
  • Nobendu Mukerjee
  • Md. Moklesur Rahman Sarker
  • Mohammad Firoz Khan
  • Md. Jamal Hossain
  • Mohammad A. Rashid
  • Ajoy Kumer
  • Arabinda Ghosh
  • Darwin A. León-Figueroa
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1140494
  • 5,120 views
  • 7 citations